An email has been sent to your address with instructions for changing your password.
There is no user registered with this email.
Sign Up
To create a free account, please fill out the form below.
Thank you for signing up!
A confirmation email has been sent to your email address. Please check your email and follow the instructions in the message to complete the registration process. If you do not receive the email, please check your spam folder or contact us for assistance.
Welcome to our platform!
Oops!
Something went wrong while trying to create your new account. Please try again and if the problem persist, Email Us to receive support.
Enpro Elects Judith A. Reinsdorf to Board of Directors
Rhea-AI Impact
(Low)
Rhea-AI Sentiment
(Neutral)
Tags
management
Rhea-AI Summary
EnPro Industries, Inc. (NYSE: NPO) has appointed Judith A. Reinsdorf to its Board of Directors. Reinsdorf previously served as Executive Vice President and General Counsel at Johnson Controls (NYSE: JCI) until her retirement in 2017. She has extensive governance experience, having chaired the Governance Committee at Alexion Pharmaceuticals and Dun & Bradstreet. David Hauser, Chairman of EnPro, expressed confidence that her leadership and strategic expertise will enhance the company's optimization and growth strategy.
Positive
Judith A. Reinsdorf brings 32 years of leadership and governance expertise.
Her experience with strategic acquisitions may benefit EnPro's growth strategy.
Appointment may strengthen the Board's oversight and strategic direction.
Negative
Concerns may arise regarding continuity in governance with a new board member.
Potential experience gaps if Reinsdorf’s background does not align with EnPro's niche markets.
CHARLOTTE, N.C.--(BUSINESS WIRE)--
EnPro Industries, Inc. (NYSE: NPO), an industrial technology company, has elected Judith A. Reinsdorf to the company’s Board of Directors.
Ms. Reinsdorf was previously Executive Vice President and General Counsel at Johnson Controls (NYSE: JCI) until her retirement in 2017. She held the same role at Tyco International from 2007 until 2016. Currently, Reinsdorf is on the Compensation Committee at Cornerstone Building Brands (NYSE: CNR), serves on the advisory board of Teach for America – New Jersey and the NACD New Jersey Chapter. Judy chaired the Governance Committee at both Alexion Pharmaceuticals, until the July 2021 acquisition by AstraZeneca, and at Dun & Bradstreet from 2013 until 2019, when the company was taken private.
Ms. Reinsdorf came to Tyco International under CEO Ed Breen’s tenure and was a key member of the transformation team at Tyco that successfully reshaped the company’s portfolio and growth strategy. During her tenure, Tyco completed several strategic acquisitions and non-core business divestitures. She began her career in 1989 as an Associate at Crowell & Moring and held various Legal Counsel positions at Monsanto, Pharmacia and C.R. Bard.
“We welcome Judy to the Enpro Board,” said David Hauser, Chairman of Enpro. “Through her 32-year career, she has demonstrated important leadership and strategic acumen, as well as governance expertise, that will benefit our company as we proceed in our optimization efforts and execute on our sharpened growth strategy.”
About Enpro
Enpro is an industrial technology company focused on niche applications across many end-markets including semiconductor, general industrial, aerospace, food and pharma and life sciences. For more information about Enpro, visit the company’s website at http://www.enproindustries.com.